Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Severe hypoglycemia may require a glucagon injection
Exenatide Extended-Release (Bydureon BCise) Bydureon BCise received FDA approval on October 20, 2017 offering a once weekly exenatide formulation
An invention was submitted for a patent on 12 November 1996 [7], and the scientific article was submitted for publication in the Journal of Clinical Investigation 20 June 1997 and published 1st February 1998 [6]
Insulin is a hormone that lowers blood sugar by increasing uptake of glucose into cells [3, 4]
,
US$ 27.92
US$ 25.81
US$ 20.82
